Dolutegravir/rilpivirine for the treatment of HIV-1 infection

Código QR

Dolutegravir/rilpivirine for the treatment of HIV-1 infection

Ellen Dowers,1 Francis Zamora,1 Lydia Aoun Barakat,2 Onyema Ogbuagu2 1Department of Pharmacy Services, Yale-New Haven Hospital, New Haven, CT, USA; 2Yale AIDS Program, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA Abstract: Much progress has been made in the...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Dowers E, Zamora F, Barakat LA, Ogbuagu O
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2018
Materias:	dolutegravir rilpivirine antiretroviral therapy HIV Immunologic diseases. Allergy RC581-607
Acceso en línea:	https://doaj.org/article/e2551025c57e4947ae941a02651ca03a
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Dolutegravir And Lamivudine Combination For The Treatment Of HIV-1 Infection
por: Zamora FJ, et al.
Publicado: (2019)

The Effect of Moderate- and High-Fat Meals on the Bioavailability of Dolutegravir/Rilpivirine Fixed-Dose Combination Tablet
por: Mehta R, et al.
Publicado: (2020)

Safety and effectiveness of switching to Abacavir/Lamivudine plus rilpivirine for maintenance therapy in virologically suppressed HIV-1 individuals in Singapore (SEALS)
por: Z. C. Lim, et al.
Publicado: (2021)

EXPERIENCE WITH DOLUTEGRAVIR IN HIV PATIENTS AT A PUBLIC SECTOR HOSPITAL IN KARACHI, PAKISTAN
por: Farzana Batool, et al.
Publicado: (2021)

Evaluating cabotegravir/rilpivirine long-acting, injectable in the treatment of HIV infection: emerging data and therapeutic potential
por: Fernandez C, et al.
Publicado: (2019)

Antiretroviral therapy interruptions: impact on HIV treatment and transmission
por: Dubrocq G, et al.
Publicado: (2018)

Factors associated with antiretroviral therapy adherence among people living with HIV in Haiti: a cross-sectional study
por: Ludentz Dorcélus, et al.
Publicado: (2021)

Elevation of immunoglobulin levels is associated with treatment failure in HIV-infected children in Vietnam
por: Dang LVP, et al.
Publicado: (2018)

Evaluation of the Sociodemographic, Behavioral and Clinical Influences on Complete Antiretroviral Therapy Adherence Among HIV-Infected Adults Receiving Medical Care in Houston, Texas
por: Sok P, et al.
Publicado: (2021)

Mother-to-Child Transmission of HIV and Its Predictors Among HIV-Exposed Infants at an Outpatient Clinic for HIV/AIDS in Vietnam
por: Nguyen RN, et al.
Publicado: (2020)

Doravirine and Its Potential in the Treatment of HIV: An Evidence-Based Review of the Emerging Data
por: Rock AE, et al.
Publicado: (2020)

Experiences and Lessons Learnt from the HIV Treat All Pilot Phase Implementation in Zimbabwe
por: Makurumidze R
Publicado: (2021)

ROLE OF HEPATITIS C VIRUS COINFECTION IN VIOLATION OF PRODUCTIVE THYMIC FUNCTION IN HIV-INFECTED PATIENTS UNDER IMMUNOLOGICALLY INEFFICIENT ANTIRETROVIRAL THERAPY
por: E. V. Saidakova, et al.
Publicado: (2014)

An update on clinical utility of rilpivirine in the management of HIV infection in treatment-naïve patients
por: Putcharoen O, et al.
Publicado: (2013)

Dyslipidemia and Associated Factors Among Adult Patients on Antiretroviral Therapy in Armed Force Comprehensive and Specialized Hospital, Addis Ababa, Ethiopia
por: Kemal A, et al.
Publicado: (2020)

Antiretroviral Treatment Failure and Associated Factors Among HIV-Infected Children on Antiretroviral Therapy: A Retrospective Study
por: Getawa S, et al.
Publicado: (2021)

Trends, treatment outcomes, and determinants for attrition among adult patients in care at a large tertiary HIV clinic in Nairobi, Kenya: a 2004–2015 retrospective cohort study
por: Mecha JO, et al.
Publicado: (2018)

Antiretroviral Therapy-Associated Metabolic Complications: Review of the Recent Studies
por: Thet D, et al.
Publicado: (2020)

Reply to Das and Berkhout, “How Polypurine Tract Changes in the HIV-1 RNA Genome Can Cause Resistance against the Integrase Inhibitor Dolutegravir”
por: Isabelle Malet, et al.
Publicado: (2018)

Antiretroviral Therapy and Retention in Care Experiences and Needs of Adolescents Living with HIV in Southern Ethiopia
por: Tunje A, et al.
Publicado: (2021)

Prevalence of Opportunistic Intestinal Parasitic Infections Among HIV/AIDS Patients Before and After Commencement of Antiretroviral Treatment at Felege Hiwot Referral Hospital: A Follow-up Study
por: Getachew T, et al.
Publicado: (2021)

Influence of Lost to Follow Up from Antiretroviral Therapy Among Retroviral Infected Patients at Tuberculosis Centers in Public Hospitals of Benishangul-Gumuz, Ethiopia
por: Degavi G
Publicado: (2021)

Prevalence Of Undernutrition And Associated Factors Among Adults Receiving First-Line Antiretroviral Treatment In Public Health Facilities Of Arba Minch Town, Southern Ethiopia
por: Oumer B, et al.
Publicado: (2019)

Profile of cabotegravir and its potential in the treatment and prevention of HIV-1 infection: evidence to date
por: Whitfield T, et al.
Publicado: (2016)

Attrition and Its Predictors Among Adults Receiving First-Line Antiretroviral Therapy in Woldia Town Public Health Facilities, Northeast Ethiopia: A Retrospective Cohort Study
por: Dejen D, et al.
Publicado: (2021)

Predictors of Clinical and Immunological Failure Among Patients on First-Line Antiretroviral Therapy (ART) in Southwest Ethiopia
por: Asefa A, et al.
Publicado: (2019)

Antiretroviral Treatment Adherence and Determinant Factors Among Adult People Infected with Human Immunodeficiency Virus in Eastern Tigray General Hospitals, Northern Ethiopia, 2019
por: Gebreagziabher TT, et al.
Publicado: (2020)

Profile of once-daily darunavir/cobicistat fixed-dose combination for the treatment of HIV/AIDS
por: Navarro J, et al.
Publicado: (2016)

Prevalence and Factors Associated with Delayed Initiation of Antiretroviral Therapy Among People Living with HIV in Nekemte Referral Hospital, Western Ethiopia
por: Bayisa L, et al.
Publicado: (2020)

Patient experiences of switching from Efavirenz- to Dolutegravir-based antiretroviral therapy: a qualitative study in Uganda
por: Adelline Twimukye, et al.
Publicado: (2021)

New option for management of HIV-1 infection in treatment-naive patients: once-daily, fixed-dose combination of rilpivirine-emtricitabine-tenofovir
por: Patel N, et al.
Publicado: (2012)

Correlates of Uptake of Antiretroviral Therapy in HIV-Positive Orphans and Vulnerable Children Aged 0–14 Years in Tanzania
por: Exavery A, et al.
Publicado: (2020)

Regulatory T cell subsets in peripheral blood of HIV-infected patients with discordant response to antiretroviral therapy
por: L. B. Korolevskaya, et al.
Publicado: (2020)

Combination therapies, effectiveness, and adherence in patients with HIV infection: clinical utility of a single tablet of emtricitabine, rilpivirine, and tenofovir
por: Wainberg MA
Publicado: (2013)

Dietary diversity and associated factors among HIV positive adults attending antiretroviral therapy clinics at Hiwot Fana and Dilchora Hospitals, eastern Ethiopia
por: Weldegebreal F, et al.
Publicado: (2018)

Unsuppressed Viral Load Level in Public Health Facilities: Nonvirological Predictors among Adult Antiretroviral Therapy Users in Southwestern Ethiopia
por: Waju B, et al.
Publicado: (2021)

Human Immune Deficiency Virus Serostatus and Associated Factors Among Children of Adult Index Cases in Northern Ethiopia
por: Mehari M, et al.
Publicado: (2021)

Increased incidences of noninfectious comorbidities among aging populations living with human immunodeficiency virus in Ecuador: a multicenter retrospective analysis
por: Hernández I, et al.
Publicado: (2019)

Potential benefit of dolutegravir once daily: efficacy and safety
por: Fantauzzi A, et al.
Publicado: (2013)

Determinants of Virological Failure Among Adult Clients on First-Line Antiretroviral Therapy in Amhara Regional State, Northeast Ethiopia. A Case –Control Study
por: Fentaw Z, et al.
Publicado: (2020)